✦ LIBER ✦

Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers

✍ Scribed by E. C. Strain; K. Stoller; S. L. Walsh; G. E. Bigelow

Publisher: Springer
Year: 2000
Tongue: English
Weight: 113 KB
Volume: 148
Category: Article
ISSN: 0033-3158
DOI: 10.1007/s002130050066

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute effects of intramuscular and subli

Acute effects of intramuscular and sublingual buprenorphine and buprenorphine/naloxone in non-dependent opioid abusers

✍ Angela N. Duke; Christopher J. Correia; Sharon L. Walsh; George E. Bigelow; Eric 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 198 KB

Effects of buprenorphine/naloxone in opi

Effects of buprenorphine/naloxone in opioid-dependent humans

✍ Kenneth B. Stoller; George E. Bigelow; Sharon L. Walsh; Eric C. Strain 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 161 KB

Buprenorphine versus methadone in the tr

Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users

✍ Eric C. Strain; Maxine L. Stitzer; Ira A. Liebson; George E. Bigelow 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 852 KB

Buprenorphine/naloxone reduces the reinf

Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers

✍ Sandra D. Comer; Ellen A. Walker; Eric D. Collins 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 201 KB

Buprenorphine and naloxone combinations:

Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers

✍ J. Mendelson; Reese T. Jones; Susette Welm; Matthew Baggott; Isabella Fernandez; 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 132 KB

Negative reinforcing properties of nalox

Negative reinforcing properties of naloxone in the non-dependent rhesus monkey: influence on reinforcing properties of codeine, tilidine, buprenorphine, and pentazocine

✍ F. Hoffmeister 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 782 KB

Scheduled infusions of naloxone (1-100 micrograms/kg/inf.) and of buprenorphine (250 micrograms/kg/inf.) generated drug avoidance behavior in the non-dependent rhesus monkey under a continuous avoidance-escape paradigm. Pentazocine (1-100 micrograms/kg/inf.) codeine, (1-100 micrograms/kg/inf. and ti